LDS/Medical Tests/Parvovirus B19, Molecular Detection, PCR

Parvovirus B19, Molecular Detection, PCR

Parvovirus B19 (B19) is a highly contagious human acquired DNA virus of the Parvoviridae family. It is the causative pathogen of a common childhood ailment, also known as Fifth Disease (erythema infectiosum) that causes a red rash on the face. It is generally a mild disease and requires little treatment if the patient is not immunocompromised. Immunocompromised adults can also be infected with Parvovirus B19 causing similar symptoms but can also include joint swelling and pain that is usually self-limited. Parvovirus B19 can also cause severe anemia (aplastic crisis) in patients who require a continual rapid production of red blood cells such as those with sickle cell anemia, red blood cell enzymopathies and autoimmune hemolytic anemia. 50% of adults have been exposed to the virus and are immune.

B19 virus infection is usually acquired by direct contact or by respiratory droplets from infected individuals. During pregnancy, B19 virus may be transmitted to the fetus resulting in hydrops fetalis and intrauterine death. There is no vaccination for Parvovirus B19 so prevention is most important. Immunity status and/or past infection can be determined from Parvovirus B19 antibody testing. Determination of B19 virus titers or acute/convalescent samples can provide significant clinical information in the assessment of individuals with suspected B19 virus infection. The presence of Parvovirus B19 IgM antibodies indicates recent infection and the presence of IgG antibodies indicates immunity or past exposure.

  • Serological determination of past, recent, or current infection with B19 virus
  • Assessment of serological status to B19 in pregnant women and others at risk including immunocompromised individuals
  • Diagnosis of fifth disease (erythema infectiosum)

Positive results, or detected nucleic acid, indicates infection with Parvovirus B19. 

Not Detected (Negative)

Real-time polymerase chain reaction (PCR), transcription mediated amplification (TMA), other molecular methods.

Serum Red top preferred, Serum gel (SST) acceptable. Whole blood EDTA (Lavender), Bone Marrow.

Plasma EDTA (Lavender), ACD (Yellow), Tissue or Body Fluid. 

Stability

  • Ambient- 48 hours
  • Refrigerated- 14 days
  • Frozen - 30 days

Store all body fluids at 4°C; store tissues at 20°C.

Rubeola antibody, Rubella antibody, Varicella antibody, Mumps antibody, Parvovirus B19 DNA by PCR, Parvovirus Tissue analysis, CBC.
1-3 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Clin Virol. 2006 May;36(1):1-7. [PMID: 16488187]
  • Annu Rev Med. 1997;48:59-67. [PMID: 9046945]
  • Clin Microbiol Rev. 2002 Jul;15(3):485-505. [PMID: 12097253]
  • Annu Rev Med. 1997;48:59-67. [PMID: 9046945]
  • Burtis C, Ashwood E, and Bruns D. Fundamentals of Clinical Chemistry. St. Louis: Saunders (2008).
  • Parvovirus B19 Antibodies, IgG and IgM, Serum. In Mayo Interpretive Handbook. Rochester: Mayo Medical Laboratories (2009).